Targeted Maximum Likelihood Based Causal Inference
暂无分享,去创建一个
[1] M. J. van der Laan,et al. Leisure-time Physical Activity and All-cause Mortality in an Elderly Cohort , 2009, Epidemiology.
[2] Readings in Targeted Maximum Likelihood Estimation , 2009 .
[3] M. Laan,et al. Selecting Optimal Treatments Based on Predictive Factors , 2009 .
[4] James M. Robins,et al. On Profile Likelihood: Comment , 2000 .
[5] J. Robins,et al. Recovery of Information and Adjustment for Dependent Censoring Using Surrogate Markers , 1992 .
[6] M. J. Laan,et al. Construction of Counterfactuals and the G-computation Formula , 2002 .
[7] Mark J van der Laan,et al. Biomarker discovery using targeted maximum‐likelihood estimation: Application to the treatment of antiretroviral‐resistant HIV infection , 2009, Statistics in medicine.
[8] James M. Robins,et al. Coarsening at Random: Characterizations, Conjectures, Counter-Examples , 1997 .
[9] M. J. van der Laan,et al. The International Journal of Biostatistics Targeted Maximum Likelihood Learning , 2011 .
[10] M. J. van der Laan,et al. The International Journal of Biostatistics Collaborative Double Robust Targeted Maximum Likelihood Estimation , 2011 .
[11] Mark J van der Laan,et al. Empirical Efficiency Maximization: Improved Locally Efficient Covariate Adjustment in Randomized Experiments and Survival Analysis , 2008, The international journal of biostatistics.
[12] K. Do,et al. Efficient and Adaptive Estimation for Semiparametric Models. , 1994 .
[13] Mark J. van der Laan,et al. Application of Time-to-Event Methods in the Assessment of Safety in Clinical Trials , 2009 .
[14] J. Robins. A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect , 1986 .
[15] M. J. Laan. Causal Effect Models for Intention to Treat and Realistic Individualized Treatment Rules , 2006 .
[16] S. Murphy,et al. Optimal dynamic treatment regimes , 2003 .
[17] M. J. van der Laan,et al. Simple Optimal Weighting of Cases and Controls in Case-Control Studies , 2008, The international journal of biostatistics.
[18] J. Robins,et al. Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.
[19] Mark J. van der Laan,et al. Why prefer double robust estimators in causal inference , 2005 .
[20] S. Murphy,et al. An experimental design for the development of adaptive treatment strategies , 2005, Statistics in medicine.
[21] Steven G. Deeks,et al. The Risk of Virologic Failure Decreases with Duration of HIV Suppression, at Greater than 50% Adherence to Antiretroviral Therapy , 2009, PloS one.
[22] M. J. Laan,et al. Double Robust Estimation in Longitudinal Marginal Structural Models , 2006 .
[23] Marshall M Joffe,et al. History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimens , 2005 .
[24] S. Keleş,et al. Statistical Applications in Genetics and Molecular Biology Asymptotic Optimality of Likelihood-Based Cross-Validation , 2011 .
[25] M. J. van der Laan,et al. Statistical methods for analyzing sequentially randomized trials. , 2007, Journal of the National Cancer Institute.
[26] Aad van der Vaart,et al. The Cross-Validated Adaptive Epsilon-Net Estimator , 2006 .
[27] Mark J. van der Laan,et al. Estimation based on case-control designs with known prevalence probability. , 2008 .
[28] J. Robins,et al. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.
[29] M. J. van der Laan,et al. Analysis of longitudinal marginal structural models. , 2004, Biostatistics.
[30] H. Strasser. Efficient and adaptive estimation for semiparametric models - P. J. Bickel; Ch. A. J. Klaassen; Ya 'acov Ritov; J. A. Wellner. , 1997 .
[31] S. Dudoit,et al. Unified Cross-Validation Methodology For Selection Among Estimators and a General Cross-Validated Adaptive Epsilon-Net Estimator: Finite Sample Oracle Inequalities and Examples , 2003 .
[32] James M. Robins,et al. Unified Methods for Censored Longitudinal Data and Causality , 2003 .
[33] Niels Keiding,et al. Statistical Models Based on Counting Processes , 1993 .
[34] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[35] Philip W. Lavori,et al. A design for testing clinical strategies: biased adaptive within‐subject randomization , 2000 .
[36] Niels Keiding,et al. Coarsening at random in general sample spaces and random censoring in continuous time , 1995 .
[37] Jasjeet S. Sekhon,et al. Multivariate and Propensity Score Matching Software with Automated Balance Optimization: The Matching Package for R , 2008 .
[38] D. Rubin,et al. Ignorability and Coarse Data , 1991 .
[39] Ree Dawson,et al. Dynamic treatment regimes: practical design considerations , 2004, Clinical trials.
[40] H. Sung,et al. Evaluating multiple treatment courses in clinical trials. , 2000, Statistics in medicine.
[41] M. J. van der Laan,et al. The International Journal of Biostatistics Causal Effect Models for Realistic Individualized Treatment and Intention to Treat Rules , 2011 .
[42] Mark J. van der Laan,et al. Targeted Methods for Biomarker Discovery, the Search for a Standard , 2008 .
[43] James M. Robins,et al. Marginal Structural Models versus Structural nested Models as Tools for Causal inference , 2000 .
[44] M J van der Laan,et al. Covariate adjustment in randomized trials with binary outcomes: Targeted maximum likelihood estimation , 2009, Statistics in medicine.
[45] Sherri Rose,et al. The International Journal of Biostatistics Why Match ? Investigating Matched Case-Control Study Designs with Causal Effect Estimation , 2011 .
[46] Daniel Weintraub,et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. , 2006, The New England journal of medicine.
[47] Mark J van der Laan,et al. Super Learning: An Application to the Prediction of HIV-1 Drug Resistance , 2007, Statistical applications in genetics and molecular biology.
[48] Peter J. Bickel,et al. INFERENCE FOR SEMIPARAMETRIC MODELS: SOME QUESTIONS AND AN ANSWER , 2001 .
[49] A. V. D. Vaart,et al. Oracle inequalities for multi-fold cross validation , 2006 .
[50] S. Dudoit,et al. Asymptotics of cross-validated risk estimation in estimator selection and performance assessment , 2005 .
[51] J M Robins,et al. Marginal Mean Models for Dynamic Regimes , 2001, Journal of the American Statistical Association.
[52] J. Pearl. Causality: Models, Reasoning and Inference , 2000 .
[53] James M. Robins,et al. Causal Inference from Complex Longitudinal Data , 1997 .
[54] Mark J. van der Laan,et al. History-Adjusted Marginal Structural Models: Time-Varying Effect Modification , 2005 .
[55] J. Robins,et al. Estimation and extrapolation of optimal treatment and testing strategies , 2008, Statistics in medicine.
[56] James M. Robins,et al. Optimal Structural Nested Models for Optimal Sequential Decisions , 2004 .
[57] G. Imbens,et al. Large Sample Properties of Matching Estimators for Average Treatment Effects , 2004 .
[58] D. Rubin. Matched Sampling for Causal Effects , 2006 .